3002.90.52/Tumor Necrosis Factor Inhibitor Injection/Canada

Tumor Necrosis Factor Inhibitor Injection from Canada

Biotech TNF-alpha inhibitor like infliximab for therapeutic treatment of rheumatoid arthritis and Crohn's disease. Classified under HTS 3002.90.52 as modified immunological products regulating immune processes. Administered via infusion for chronic inflammation.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Black box warning documentation may expedite review

• Ensure monoclonal specificity testing for classification

• Volume limits for personal import under traveler exemptions

Tumor Necrosis Factor Inhibitor Injection from Canada — Import Duty Rate | HTS 3002.90.52